Literature DB >> 9850988

Increase in urinary peptides prior to the diagnosis of schizophrenia.

K L Reichelt, M Stensrud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850988     DOI: 10.1016/s0920-9964(98)00104-2

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  Gastrointestinal inflammation and associated immune activation in schizophrenia.

Authors:  Emily G Severance; Armin Alaedini; Shuojia Yang; Meredith Halling; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2012-03-24       Impact factor: 4.939

2.  Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder.

Authors:  Emily G Severance; Kristin L Gressitt; Shuojia Yang; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Faith B Dickerson; Robert H Yolken
Journal:  Bipolar Disord       Date:  2013-12-06       Impact factor: 6.744

Review 3.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

4.  Anti-gluten immune response following Toxoplasma gondii infection in mice.

Authors:  Emily G Severance; Geetha Kannan; Kristin L Gressitt; Jianchun Xiao; Armin Alaedini; Mikhail V Pletnikov; Robert H Yolken
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

Review 5.  Autoimmune phenotypes in schizophrenia reveal novel treatment targets.

Authors:  Emily G Severance; Faith B Dickerson; Robert H Yolken
Journal:  Pharmacol Ther       Date:  2018-05-06       Impact factor: 12.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.